GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Curocell Inc (XKRX:372320) » Definitions » Insider Ownership

Curocell (XKRX:372320) Insider Ownership : 0.00 % (As of Jun. 05, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Curocell Insider Ownership?

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Curocell's insider ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Curocell's Institutional Ownership is 0.80%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Curocell's Float Percentage Of Total Shares Outstanding is 0.00%.


Curocell Insider Ownership Historical Data

The historical data trend for Curocell's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curocell Insider Ownership Chart

Curocell Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Insider Ownership
- - - - -

Curocell Semi-Annual Data
Jun22 Dec22 Jun23 Dec23
Insider Ownership - - - -

Curocell Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.


Curocell (XKRX:372320) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
11, Gukjegwahak 16-ro, Yuseong-gu, Daejeon, KOR, 34002
Curocell Inc is engaged in medical and pharmaceutical research and development. The company is into development of CAR-T treatments that enhance the natural function of immune cells to eliminate cancer cells through genetic manipulation of human immune cells.

Curocell (XKRX:372320) Headlines

No Headlines